Scholarly Index
C. Daniel Mullins
University of Maryland, Baltimore; 15,514 total citations; 588 total publications; best world rank #87
University of Maryland, Baltimore
15,514Total citations
588Total publications
56H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmaceutical Economics and Policy | Lifetime | 87 | US 46 | 98.35 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 618 | US 290 | 98.53 |
| Pharmaceutical studies and practices | Lifetime | 386 | US 188 | 97.15 |
| Economic and Financial Impacts of Cancer | Lifetime | 278 | US 180 | 96.82 |
| Healthcare cost, quality, practices | Lifetime | 292 | US 161 | 96.33 |
| Healthcare Policy and Management | Lifetime | 826 | US 572 | 96.47 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 622 | US 248 | 95.98 |
| Health Policy Implementation Science | Lifetime | 457 | US 222 | 96.12 |
| Mental Health and Patient Involvement | Lifetime | 312 | US 101 | 95.48 |
| Medication Adherence and Compliance | Lifetime | 372 | US 214 | 94.93 |
| Patient-Provider Communication in Healthcare | Lifetime | 758 | US 363 | 94.01 |
| Pharmaceutical industry and healthcare | Lifetime | 227 | US 140 | 92.91 |
| Ethics in Clinical Research | Lifetime | 744 | US 392 | 91.24 |
| Healthcare cost, quality, practices | 2021-2025 | 331 | US 145 | 84.88 |